Headlands Technologies’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $861K | Buy |
6,852
+4,930
| +257% | +$620K | 0.1% | 209 |
|
|
2025
Q1 | $213K | Sell |
1,922
-3,915
| -67% | -$433K | 0.02% | 446 |
|
|
2024
Q4 | $797K | Sell |
5,837
-13,566
| -70% | -$1.85M | 0.08% | 250 |
|
|
2024
Q3 | $2.24M | Buy |
19,403
+10,340
| +114% | +$1.19M | 0.26% | 87 |
|
|
2024
Q2 | $1.25M | Buy |
9,063
+8,865
| +4,477% | +$1.22M | 0.13% | 142 |
|
|
2024
Q1 | $27.3K | Sell |
198
-1,356
| -87% | -$187K | 0.01% | 848 |
|
|
2023
Q4 | $205K | Sell |
1,554
-8,799
| -85% | -$1.16M | 0.06% | 271 |
|
|
2023
Q3 | $1.16M | Buy |
10,353
+2,762
| +36% | +$311K | 0.57% | 41 |
|
|
2023
Q2 | $716K | Buy |
+7,591
| New | +$716K | 0.23% | 107 |
|